Engineers Gate Manager LP Cytosorbents Corp Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $115,552 - $211,409	-65,655 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $19,376 - $28,459	-6,728 Reduced 9.3%	65,655 $209,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $293,151 - $587,026	72,383 New	72,383 $303,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $464,247 - $544,960	-60,686 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.37 - $11.54 $98,765 - $154,647	-13,401 Reduced 18.09%	60,686 $484,000

Q2 2020 Aug 17, 2020	BUY	$6.28 - $10.59 $465,266 - $784,581	74,087 New	74,087 $733,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $81,677 - $167,470	-21,665 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $5,620 - $8,127	1,557 Added 7.74%	21,665 $83,000
Q3 2019 Nov 14, 2019	BUY	$4.33 - $7.63 $87,067 - $153,424	20,108 New	20,108 $101,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $30.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.